Patients with rheumatic complaints in a broader sense prior to diagnosis M00-M99 L40
Conditions
Interventions
Group 1: RhePort-Cohort: New patients receive their initial appointment scheduled through RhePort. Medical data is collected, including the diagnosis, disease activity, and pain activity, as well as d
Sponsors
RheumaDatenRhePort (Rhadar) GbR
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: new appointments in the corresponding rheumatology center publicly health-insured no confirmed diagnosis of an inflammatory rheumatic disease
Exclusion criteria
Exclusion criteria: insured through private health insurance
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of diagnoses for inflammatory rheumatic vs. non-inflammatory rheumatic diseases in the cohort of New Patients | — |
Secondary
| Measure | Time frame |
|---|---|
| • Duration from first appointment request to actual appointment, depending on the different appointment scheduling systems (e.g., RhePort, GP-mediated appointments) • Exploratory investigation: Examining a potential correlation between the score assigned by RhePort and indication-specific disease activity scores or assessments • Examining the difference in indication-specific disease activity scores between the RhePort cohort and the non-RhePort cohort • Proportion of correctly identified positive patients (patients with an inflammatory rheumatic diagnosis vs. non-inflammatory) through RhePort | — |
Countries
Germany
Contacts
Public ContactSarah Wildenhain
Libertamed GmbH
Outcome results
None listed